BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

  August 12, 2024

   · 

  1 min read
• Press Releases

  Britannia Life Sciences Inc. Provides Update on Cease Trade Order

  August 12, 2024

   · 

  3 min read
• Press Releases

  Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights

  August 12, 2024

   · 

  7 min read
• Business

  Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

  August 12, 2024

   · 

  10 min read
• FDA

  Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD

  August 12, 2024

   · 

  4 min read
• Press Releases

  Sernova Corp. Announces Appointment of New Chief Executive Officer

  August 12, 2024

   · 

  5 min read
• Press Releases

  Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference

  August 12, 2024

   · 

  9 min read
• Press Releases

  Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission

  August 12, 2024

   · 

  9 min read
• Press Releases

  MBX Biosciences Doses First Patient in Phase 2 Avail™ Trial of MBX 2109 for the Treatment of Hypoparathyroidism

  August 12, 2024

   · 

  5 min read
• Press Releases

  Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update

  August 12, 2024

   · 

  13 min read